Nykredit A S Makes New $55.89 Million Investment in Intuitive Surgical, Inc. $ISRG

Key Points

• Nykredit A/S purchased 140,548 shares of Intuitive Surgical in the second quarter, establishing a stake worth approximately $55.9 million. Institutional investors and hedge funds collectively own 83.64% of the company.
• Analysts maintain a generally positive outlook, with 22 Buy ratings, eight Holds and one Sell; the stock has a “Moderate Buy” consensus rating and an average price target of $508.68.
• Intuitive Surgical exceeded quarterly expectations, reporting EPS of $2.80 versus the $2.48 consensus and revenue of $2.89 billion, up 18.4% year over year. Shares opened at $371.88, well below their 52-week high of $603.88.

Nykredit A S bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 140,548 shares of the medical equipment provider's stock, valued at approximately $55,893,000.

A number of other large investors have also recently made changes to their positions in ISRG. Main Street Group LTD acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. Compass Financial Management LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at $30,000. Vermillion Wealth Management Inc. raised its position in Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider's stock valued at $31,000 after purchasing an additional 25 shares during the last quarter. Motiv8 Investments LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at $34,000. Finally, Evergreen Advisors LLC acquired a new stake in Intuitive Surgical during the 1st quarter worth $35,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Oppenheimer upgraded shares of Intuitive Surgical from a "market perform" rating to an "outperform" rating and set a $500.00 price objective on the stock in a research note on Wednesday, August 12th. The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research note on Wednesday, May 27th. UBS Group assumed coverage on Intuitive Surgical in a report on Tuesday, July 28th. They set a "neutral" rating and a $500.00 price target on the stock. HSBC cut Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Finally, Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Twenty-two analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $508.68.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 400 shares of the business's stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the director owned 251 shares in the company, valued at approximately $95,129. The trade was a 61.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the transaction, the executive vice president directly owned 5,320 shares of the company's stock, valued at approximately $2,016,280. This trade represents a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 11,658 shares of company stock worth $4,649,835. Company insiders own 0.60% of the company's stock.

Intuitive Surgical Stock Up 0.7%

Shares of NASDAQ:ISRG opened at $371.88 on Thursday. The company has a market cap of $131.38 billion, a price-to-earnings ratio of 42.60, a PEG ratio of 2.79 and a beta of 1.47. The firm's 50-day simple moving average is $382.80 and its 200-day simple moving average is $429.86. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business's revenue was up 18.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.81 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source